Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exagen (XGN) EPS (Basic) (2018 - 2025)

Historic EPS (Basic) for Exagen (XGN) over the last 8 years, with Q3 2025 value amounting to -$0.31.

  • Exagen's EPS (Basic) fell 1071.43% to -$0.31 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.92, marking a year-over-year increase of 212.77%. This contributed to the annual value of -$0.83 for FY2024, which is 3803.32% up from last year.
  • Per Exagen's latest filing, its EPS (Basic) stood at -$0.31 for Q3 2025, which was down 1071.43% from -$0.21 recorded in Q2 2025.
  • In the past 5 years, Exagen's EPS (Basic) registered a high of -$0.16 during Q2 2024, and its lowest value of -$0.88 during Q4 2022.
  • Its 5-year average for EPS (Basic) is -$0.39, with a median of -$0.31 in 2023.
  • Per our database at Business Quant, Exagen's EPS (Basic) crashed by 12631.58% in 2022 and then skyrocketed by 6744.19% in 2023.
  • Quarter analysis of 5 years shows Exagen's EPS (Basic) stood at -$0.44 in 2021, then plummeted by 100.41% to -$0.88 in 2022, then soared by 64.97% to -$0.31 in 2023, then soared by 33.35% to -$0.21 in 2024, then plummeted by 50.04% to -$0.31 in 2025.
  • Its last three reported values are -$0.31 in Q3 2025, -$0.21 for Q2 2025, and -$0.2 during Q1 2025.